Home›Companies›Biotech & Pharma›Parley Neurotech

Parley Neurotech Inc.

Develops a treatment for people who struggle to hear conversations in noisy places.

Updated Nov 10, 2026·Latest SEC filing Jun 17, 2026·Suggest an edit

About Parley Neurotech

Parley Neurotech is a private company based in Denver, Colorado, incorporated in 2025 in Delaware. It has reported $140,000 raised in one offering on Form D since June 2026. Its chief executive is Samuel Budoff.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 12, 2026Jun 17, 2026$140,000of $300K target3$46,667EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Parley Neurotech's Form D filed Jun 17, 2026.

Achim Klug
Achim Klug
PhD - CSO, Co-Founder
Samuel Budoff
Samuel Budoff
PhD - CEO, Co-Founder

Sources

  1. SECPARLEY NEUROTECH INC filing history
  2. CompanyPrivacy policy
  3. CompanyAbout Parley Neurotech